» Download Public Reports
About 800 reports
- Country report
- March 2013
- 40 pages
... Products with a strong manufacturing base. India continues to gain traction as one of the most prominent countries with an exceptional capability to act as a sourcing point for quality generic medicines ...
April 2013
... Decreased from ~50% of the overall statin market to ~40% this year while the atorvastatin market has grown. It is because generic atorvastatin is taking the market share away from the innovator brand ...
April 2013
... Decreased from ~50% of the overall statin market to ~40% this year while the atorvastatin market has grown. It is because generic atorvastatin is taking the market share away from the innovator brand ...
March 2013
... Information, please visit www.Ibef.Org growth drivers launch of patented drugs Following the introduction of product patents, several multinational companies are expected to launch patented drugs in india ...
April 2013
... The policy framework evolved thus far that are likely to affect the availability of drugs and their prices in the coming years. It also discusses issues such as liberalization of trade, investment ...
April 2013
... Raipur, chhattisgarh in collaboration with who, who, new delhi. 30/04/2013 The objectives To document the availability and price of key essential medicines for children in the state ...
» Purchase Premium Reports
(From $ 125 - $ 4 995)
About 200 reports
- $ 4 995
- Industry report
- February 2013
- by Global Data
PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis ...
May 2013
$ 5 174
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
April 2013
$ 3 500
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants ...
March 2013
$ 2 000
Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'Meningococcemia (Meningococcal Infections) - Pipeline Review, H1 2013', provides an overview of ...
April 2013
$ 1 088
Includes 3 FREE quarterly updates BMI View: India's pharmaceutical industry is highly attractive to drugmakers but it also has several negative characteristics. Combined revenues of over-the-counter (OTC) ...
May 2013
$ 652
This market research report offers a perspective on the actual market situation, trends and future outlook for vaccines in India. The study provides essential market information for decision-makers including: ...
March 2013
$ 300
Summary Camlin Fine Sciences Limited (CFS) is a food antioxidant and ingredient manufacturing company, based in India. The company manufactures and exports bulk drugs, fine chemicals and food grade products. ...